Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen.
暂无分享,去创建一个
F. Lescure | G. Pialoux | P. Soussan | L. Slama | P. Bonnard | F. Bani-Sadr | T. Galpérine | C. Le Pendeven | C. Fontaine | C. Chakvetadze | P. Mariot
[1] C. Mengoli,et al. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. , 2009, Vaccine.
[2] S. Grabar,et al. Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study , 2008, Journal of acquired immune deficiency syndromes.
[3] S. Alavian,et al. Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs , 2008, Human vaccines.
[4] J. Angel,et al. CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] R. Bruno,et al. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults , 2008, HIV medicine.
[6] C. Leport,et al. Occult hepatitis B in HIV-HCV coinfected patients , 2008, Scandinavian journal of infectious diseases.
[7] M. Young,et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. , 2007, The Journal of infectious diseases.
[8] P. Sax,et al. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. , 2005, The Journal of infectious diseases.
[9] Giorgio Palù,et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. , 2005, Journal of hepatology.
[10] M. Wallace,et al. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] D. Neau,et al. Isolated antibodies against the core antigen of hepatitis B virus in HIV‐infected patients , 2004, HIV medicine.
[12] A. Lechi,et al. Isolated presence of antibody to hepatitis B core antigen in injection drug users: do they need to be vaccinated? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] J. Lang,et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. , 2000, Vaccine.
[14] K. Meyer zum Büschenfelde,et al. Kinetics of hepatitis B surface antigen–specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of the in vitro antibody response by interferon gamma , 1999, Hepatology.
[15] B. McMahon,et al. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] A. Rosman,et al. Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial. , 1997, The American journal of medicine.
[17] I. Symington,et al. Influence of smoking on immunological responses to hepatitis B vaccine. , 1994, Vaccine.
[18] B. McMahon,et al. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. , 1992, Gastroenterology.